ArticleCellular and molecular bioengineering2020

Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers.

Matthew R Aronson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.